Fate Therapeutics
FATE
$4.79
Share price
-4.96%
Change (1 day)
-25.27%
Change (1 year)
Categories
Market capitalization of Fate Therapeutics (FATE)
Market cap: $0.54 Billion
As of April 2024 Fate Therapeutics has a market cap of $0.54 Billion. This makes Fate Therapeutics the world's 5833th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Fate Therapeutics from 2013 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $0.54 B | 47.79% |
| 2023 | $0.36 B | -62.39% |
| 2022 | $0.98 B | -82.45% |
| 2021 | $5.58 B | -29.57% |
| 2020 | $7.93 B | 435.28% |
| 2019 | $1.48 B | 78.55% |
| 2018 | $0.83 B | 158.07% |
| 2017 | $0.32 B | 209.62% |
| 2016 | $0.10 B | 7.34% |
| 2015 | $96.77 M | -6.47% |
| 2014 | $0.10 B | -19.37% |
| 2013 | $0.12 B |
End of Day market cap according to different sources
On Apr 19th, 2024 the market cap of Fate Therapeutics was reported to be:
$0.54 Billion
$0.54 Billion
$0.47 Billion
$0.54 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Becton Dickinson BDX | $67.63 B | 12,310.13% | 🇺🇸 USA |
 Sarepta Therapeutics
SRPT | $10.85 B | 1,891.04% | 🇺🇸 USA |
 PTC Therapeutics
PTCT | $1.93 B | 255.90% | 🇺🇸 USA |
 Neurocrine Biosciences
NBIX | $13.27 B | 2,335.97% | 🇺🇸 USA |
 Avidity Biosciences RNA | $1.81 B | 232.47% | 🇺🇸 USA |